Zdrowie i gospodarka · 22/12/2022

FDA Releases Draft Guidance for Industry on Controlled Correspondence Related to Generic Drug Development

The US Food and Drug Administration (FDA) has made available a draft guidance document that outlines the process for generic drug manufacturers to submit requests for information and clarify ambiguities in FDA's responses, as part of its efforts to facilitate communication and collaboration in the development of generic drugs.